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I t has been known for many years that 
certain autonomic drugs cause changes in 
portal hemodynamics. In 1909, Schmidl* 
demonstrated that epinephrine caused a 
transient rise in portal pressure. In 1928, 
Clark7 and later McMichael17 and others 
showed that pitressin caused a temporary 
fall. These findings were chiefly of physi- 
ologic interest until recently. However, in 
1956, Kehne and associates13 and subse- 
quently Schwartz and his grouplg demon- 
strated that pitressin was of value for lower- 
ing the portal pressure in patients with 
bleeding esophageal varices. Davis and col- 
leaguess showed the same effect by direct 
- 
esophagoscopic examination and by intra- 
splenic pulp pressure measurements. Since 
the publication of these reports, studies by 
Eiseman1° and Johnsonl1 and their associates 
have focused on the possibility that this 
effect is due to pharmacologically induced 
closure of arteriovenous shunts in the gastro- 
intestinal tract. More recently, it has been 
shown by Cincotti and co-workers6 that 
Arfonad, one of the ganglionic blocking 
agents, also causes a reduction of portal 
pressure. 
The purpose of the present study was to 
determine what role the liver itself had in 
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the portal pressure changes evoked by epi- 
nephrine, pitressin, and Arfonad. The results 
of these experiments tend to verify some ac- 
cepted beliefs as to the reason why these 
drugs alter portal pressure. However, they 
also show that other accepted mechanisms 
may be incomplete. 
METHODS 
Fifty-five mongrel dogs which weighed 7 
to 18 kilograms were used. For all pressure 
studies the dogs were anesthetized with 23 to 
27 mg. per kilogram of pentobarbital so- 
dium. A citrate-filled polyethylene catheter 
was placed in a carotid artery and connected 
to an aneroid manometer for arterial pres- 
sure (Fig. 1) .  A similar catheter was placed 
in the inferior vena cava via a femoral vein 
and a smaller catheter passed into the portal 
vein via one of the mesenteric radicles (Fig. 
1 ) .  The venous catheters were attached to 
glass manometers which were leveled with 
the anterior vertebral bodies of the upper 
lumbar vertebrae by the method of Taylor 
and Herbert.23 
In all experiments, only 1 drug was used. 
The test dose of epinephrine was 0.25 ml. of 
1/1000 solution. The test dose of pitressin 
was 10 U. The pitressin and epinephrine 
were diluted in 35 ml. saline solution and 
given into a foreleg vein. The injections 
were made with a constant infusion pump 
(Fig. 1) in 5 minutes, after preliminary 
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demonstration that similar control injections 
with saline solution did not affect any of 
the pressures. Arfonad was diluted with 
saline solution to 0.1 mg. per milliliter and 
given intravenously at whatever rate was 
necessary to obtain the desired hypotensive 
effect. 
Experiments were carried out in normal 
dogs and in dogs with portacaval transpo- 
sition. In some instances the operation had 
been performed from 2 weeks to 2 months 
prior to testing, and in others the tests were 
performed approximately 2 hours after com- 
pletion of operation. The transposition was 
accomplished by a technique developed in 
this l a b o r a t ~ r y . ~ ~  The method consisted of 
portacaval transposition above the level of 
the adrenal veins and proximal to all the 
tributaries of the portal vein. 
RESULTS 
The effect of epinephrine. 
Normal dogs. Seven normal dogs were 
studied. The results were the same in all 
experiments and conformed to those of pre- 
vious  investigator^.^, 5 9  l2 Pressure changes 
generally lasted less than 10 to 15 minutes. 
The arterial, vena caval, and portal pres- 
sures all rose (Fig. 2, A) .  In every case the 
portal rose more than the vena caval pres- 
sure. The average rise in portal pressure 
was 131 mm. citrate, and the rise in vena 
caval pressure averaged 41 mm. citrate (Fig. 
5, A).  
Dogs wi th  portacaval transposition. Twelve 
dogs were studied. The duration of pharma- 
cologic effect was generally less than 10 to 
15 minutes. The arterial pressure rose in all 
cases. Pressures in the inferior vena cava, 
proximal to the hepatic capillary bed (Fig. 
2, B),  rose in all 12 dogs. The average in- 
crease was 128 mm. citrate. Pressures in the 
portal vein which now connected directly 
into the systemic circulation were increased 
in 1 1 dogs and decreased in 1. The average 
change of portal vein pressure for all 12 dogs 
was a 35 mm. citrate rise (Fig. 5, A). 
The effect of pitressin. 
Normal  dogs. Seven normal dogs were 
tested. The arterial pressure rose in all, 
usually only slightly (Fig. 3, A) .  The portal 
pressure declined in all 7 dogs (Fig. 3, A), 
the average drop being 31 mm. citrate (Fig. 
5, B) . In 5 of the 7 animals, rises were noted 
in the vena caval pressure and in the other 
2 it remained the same. The average change 
in the vena caval pressure of the 7 dogs 
was a 7 mrn. saline increase (Fig. 5, B).  In 
most dogs the various pressure changes lasted 
for 20 to 30 minutes. 
Dogs wi th  portacaval transposition. Seven 
dogs with portacaval transposition were 
tested. Five of the animals were studied 
within 2 hours after the operation, and the 
other 2 were studied 2 months after opera- 
tion. In  all 7 experiments, the arterial pres- 
sure rose (Fig. 3, B). The vena caval pres- 
sure proximal to the hepatic capillary bed 
fell in all 7 dogs (Fig. 3, B). The average 
change in the 7 dogs was an 18.5 mm. citrate 
decline (Fig. 5, B) . In the portal vein, which 
had been redirected into the proximal vena 
cava, the pressure fell in 6 of 7 experiments 
(Fig. 3, B),  and was unchanged in the 
other. The average change for the 7 dogs 
Fig. 1. Experimental setup used for pressure de- 
terminations and drug administration. 
366 Butz et al. Surgery 
March 1962 
was a fall in the portal pressure of 35 mm. 
citrate solution (Fig. 5, B) . 
The effect of Arfonad. 
Norm,al dogs. The hypotensive response 
was used as a guide for the administration 
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Fig. 2. Effect of epinephrine on vascular pressures 
in ( A )  normal dog and ( B )  dog with portacaval 
transposition. 
60 
of Arfonad. The blood pressure dropped 
from 15 to 70 mm. Hg during the test 
period (Fig. 4, A ) .  In  6 of the 7 dogs, the 
portal pressure declined and in the other it 
was unchanged. The average portal pres- 
sure change was a 22 mm. citrate fall 
(Fig. 5, C ) .  The vena caval pressure rose 
slightly in 4 dogs, was unchanged in 1, and 
fell in the other 2. After cessation of admin- 
istration of Arfonad, the venous pressures re- 
turned to control values concomitantly with 
the restoration of the arterial pressures (Fig. 
4, A ) .  
Dogs with portacava2 transposition. Fifteen 
dogs were tested, 4 immediately after trans- 
position and 11 in 2 * weeks or more after 
operation. The vena caval pressure proximal 
to the hepatic capillary bed rose in 7 ani- 
mals (Fig. 4, B), was unchanged in 6, and 
fell in 2. In the portal vein, which drained 
into the proximal vena cava, the pressure 
fell in 11 dogs (Fig. 4, B), was unchanged 
in 2, and increased in 2. The average change 
in portal pressure in all 15 dogs was a 22 
mm. citrate fall (~ig-: 5, C )  . 
- m.m. C~f ra te  
DISCUSSION 
In the interpretation and application of 
any study such as the present one, the species 
difference between the experimental animal 
and man is always carefully considered. Such 
a precaution is especially germane when dogs 
are used for portal pressure studies. The 
intrahepatic venules and veins have ex- 
tremely well-developed smooth muscle coats 
in the dog,l and these are thought to pro- 
vide unusual control of hepatic vascular re- 
~istance.~, 4 3  ', 16, '3 24 This anatomic feature 
is absent or poorly represented in man and 
most other species.l Furthermore, the ca- 
pacity for vasomotor change in the human 
liver may be further decreased by the pres- 
ence of cirrhosis, the very situation in which 
drugs would be used to alter portal pres- 
sure. 
With this reservation in mind, the present 
study was designed to determine what role 
the liver played in the action of various 
autonomic drugs on portal pressure. Trans- 
position of the vessels deviated the splanch- 
Volume 51 
Number 3 
Autonomic drug e f e c t  on portal hemodynamics 367 
nic drainage directly into the central venous 
pool and precluded a hepatic factor from 
influence on portal pressure. Conversely, the 
vena caval pressure was brought under the 
influence of changes in resistance of the 
hepatic vascular bed. The testing procedures 
used were performed in exactly the same 
way in every experiment. The constant in- 
fusion pump which was used to inject all 
drugs except Arfonad added a uniformity 
which has often not been present in other 
studies of autonomic agents. 
With an injection of epinephrine, the rise 
in portal pressure appeared largely to be re- 
lated to the necessity for the splanchnic 
venous blood to pass through the liver. When 
transposition was performed, rises in portal 
pressure were small. By contrast, the trans- 
hepatically directed vena cava now exhibited 
major increases compared to small pressure 
rises in the normal animal. Theoretically, 
these pressure changes could be explained 
by the assumption that the liver imposed a 
fixed resistance to venous blood transport, 
and that epinephrine greatly increased the 
Caval pressure 
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Fig. 3. Effect of pitressin on vascular pressures in 
( A )  normal dog and (B) dog with portacaval 
transposition. 
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Fig. 4. Effect of Arfonad on vascular pressures in 
( A )  normal dog and ( B )  dog with portacaval 
transposition. 
venous return in both the portal vein and 
vena cava. In  this way the venous channel 
passing through the liver would have a dis- 
proportionate rise in pressure due solely to 
an increased flow rate. There is, however, 
overwhelming e v i d e n ~ e ~ - ~ *  9 3  153 l61 2 0 ~  25 that 
the liver plays more than a passive role 
after administration of epinephrine, and its 
vascular bed undergoes active constriction. 
Recently, Eisemanl0 and Johnsonl1 and 
their associates have presented an explana- 
tion for the clinically important fact that 
intravenous pitressin causes a fall in portal 
pressure. Their data indicated that pitressin 
prompted closure of arteriovenous enteric 
shunts, thereby reducing the volume of por- 
tal blood flow. The present experiments sup- 
port such a concept of peripheral action, 
inasmuch as substantial reductions in portal 
pressure were seen after transposition. 
The present studies, however, also focus 
attention on an auxiliary mechanism for 
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Fig. 5. Average pressure changes with administration of ( A )  epinephrine, (B)  pitres- 
sin and (C)  Arfonad. 
pitressin-induced reduction of portal pres- 
sure involving a fall of hepatic vascular re- 
sistance. In animals in the normal state, 
pitressin usually caused a slight rise in vena 
caval pressure. When the vena caval flow 
was directed through the liver, pitressin 
caused a reverse effect with a pressure fall 
in every case. In the treatment of portal 
hypertension, this factor is probably of 
limited significance since the rigid and 
fibrosed liver has probably lost much of its 
capacity for direct vascular response. 
The present study indicates that Arfonad 
has no direct action on the hepatic vascular 
system and that its principal effect is on the 
peripheral splanchnic bed. A consistent fall 
in portal pressure was observed whether the 
splanchnic flow was or was not passing 
through the liver. Similarly, the pressure be- 
havior of the transposed vena cava was not 
changed from that seen in normal dogs. 
Whether the extrahepatic effect of portal 
pressure reduction with Arfonad is due to a 
simple reduction in arterial inflow, to closure 
of arteriovenous shunts, or to some other 
mechanisms is not clear. 
SUMMARY 
The effect of epinephrine, pitressin, and 
Arfonad on portal pressure has been studied 
in dogs with special emphasis on the role 
of the liver in determining pressure changes. 
The use of dogs with portacaval transpo- 
sition allowed portal pressures to be studied 
with the exclusion of any hepatic vascular 
factor. With this preparation, vena caval 
pressures were brought under the influence 
of changes in hepatic vascular resistance. 
By this technique, the action of epi- 
nephrine in raising portal pressure primarily 
seemed to be due to an increase in hepatic 
vascular resistance. The action of pitressin 
in reducing portal pressure appeared to be 
due to a combination of reduction of 
splanchnic blood flow and a reduction in 
hepatic vascular resistance. The effect of 
Arfonad in lowering portal pressure ap- 
peared to be unrelated to any changes in 
the liver itself. 
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